PharmaCyte Biotech, Inc.

CIK 0001157075 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols

PMCB on Nasdaq

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal

Parsed SEC ownership signals

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

QCLS

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

FEMY

How to read these SEC ownership signals

• Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
• Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
• Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields

SEC industry group

Biological Products, (No Disgnostic Substances) (Office of Life Sciences)

Business address

3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV, 89169

EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available

Incorporated in

NV

Fiscal year end

30 April

Former names on EDGAR

NUVILEX, INC. (to 09 Jan 2015), EFOODSAFETY COM INC (to 17 Mar 2009)